John P. Neoptolemos
- Oncology top 0.01%
- Pancreatic and Hepatic Oncology Research 303
- Surgery top 0.01%
- Pancreatitis Pathology and Treatment 199
- Pediatric Hepatobiliary Diseases and Treatments 42
- Gastrointestinal disorders and treatments 40
- Cancer Research top 0.05%
- Cancer Genomics and Diagnostics 83
- Pulmonary and Respiratory Medicine top 0.05%
- Gallbladder and Bile Duct Disorders 68
- Renal cell carcinoma treatment 35
- Gastroenterology top 0.2%
-
- Neuroendocrine Tumor Research Advances 69
- Co-authors
- Paula GhanehClaudio BassiChristos DervenisMarkus W. BüchlerJakob R. IzbickiMichael G. SarrCharles J. YeoAbe Fingerhut
- Cited by
- OncologySurgeryCancer Research
- Journals
- New England Journal of Medicine (1 paper)Proceedings of the National Academy of Sciences (2 papers)The Lancet (4 papers)
- Partner nations
- United KingdomGermanyUnited States
In The Last Decade
John P. Neoptolemos
509 papers receiving 39.2k citations
Hit Papers
Peers
Comparison fields: 5 of 175
- Oncology 28.3k
- Surgery 21.6k
- Cancer Research 6.4k
- Pulmonary and Respiratory Medicine 11.9k
- Gastroenterology 1.3k
Countries citing papers authored by John P. Neoptolemos
This map shows the geographic impact of John P. Neoptolemos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John P. Neoptolemos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John P. Neoptolemos more than expected).
Fields of papers citing papers by John P. Neoptolemos
This network shows the impact of papers produced by John P. Neoptolemos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John P. Neoptolemos. The network helps show where John P. Neoptolemos may publish in the future.
Co-authorship network
The 25 scholars most cited alongside John P. Neoptolemos, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2023 | 5 | |
| 3 | 2023 | 2 | |
| 4 | 2021 | 37 | |
| 5 | 2020 | 25 | |
| 6 | 2020 | 15 | |
| 7 | 2020 | 19 | |
| 8 | 2016 | 67 | |
| 9 | 2015 | 148 | |
| 10 | 2014 | 34 | |
| 11 | 2005 | 114 | |
| 12 | 2005 | 70 | |
| 13 | 2004 | 397 | |
| 14 | 2001 | 5 | |
| 15 | 1999 | 104 | |
| 16 | Meta-analysis of adjuvant chemoradiotherapy and chemotherapy for resectable pancreatic cancer including the final results of the ESPAC-1 trial | 1998 | 2 |
| 17 | Low mortality following resection for pancreatic and periampullary tumours in 1026 patients: UK survey of specialist pancreatic units. UK Pancreatic Cancer Group. | 1997 | 278 |
| 18 | 1996 | 26 | |
| 19 | 1994 | 116 | |
| 20 | 1985 | 8 |
About John P. Neoptolemos
John P. Neoptolemos is a scholar working on Oncology, Cancer Research and Surgery, having authored 517 papers that have together received 40.2k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (303 papers), Pancreatitis Pathology and Treatment (199 papers), Cancer Genomics and Diagnostics (83 papers), Neuroendocrine Tumor Research Advances (69 papers), Gallbladder and Bile Duct Disorders (68 papers), Pediatric Hepatobiliary Diseases and Treatments (42 papers), Gastrointestinal disorders and treatments (40 papers) and Renal cell carcinoma treatment (35 papers). The work is most often cited by research in Oncology (28.3k citations), Surgery (21.6k citations) and Cancer Research (6.4k citations). John P. Neoptolemos has collaborated with scholars based in United Kingdom, Germany and United States. Frequent co-authors include Paula Ghaneh, Claudio Bassi, Christos Dervenis, Markus W. Büchler, Jakob R. Izbicki, Michael G. Sarr, Charles J. Yeo, Abe Fingerhut, Robert Sutton and Michael Raraty. Their work appears in journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.